Contact
Subscribe
e-Edition

Dashboard
Logout

- My Account
- Dashboard
- Profile
- Saved items
- Logout

Facebook
Twitter
Instagram

30° Clear
- Guymon, OK (73942)
  Today
  
  Sunny to partly cloudy. High 67F. Winds NNW at 5 to 10 mph..
  
  Tonight
  
  Mostly clear. Low 29F. Winds NNW at 5 to 10 mph.
  
  Updated: December 16, 2025 @ 7:37 am
- Full Forecast

Site search

Home
News
- Local News
Sports
Entertainment
Obituaries
Photos
Videos
e-Edition
Classifieds
Archives
Best of 2025

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Apellis Pharmaceuticals, Inc. - Common Stock (NQ:APLS)

24.73 +0.17 (+0.67%)

Streaming Delayed Price Updated: 9:54 AM EST, Dec 16, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Apellis Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

12 13 Next >

Peeling Back The Layers: Exploring Apellis Pharmaceuticals Through Analyst Insights ↗

July 17, 2024

Via Benzinga

What Analysts Are Saying About Apellis Pharmaceuticals Stock ↗

June 28, 2024

Via Benzinga

Nike, Accolade And Other Big Stocks Moving Lower In Friday's Pre-Market Session ↗

June 28, 2024

Via Benzinga

Expert Outlook: Apellis Pharmaceuticals Through The Eyes Of 15 Analysts ↗

May 28, 2024

Via Benzinga

In-Depth Examination Of 14 Analyst Recommendations For Apellis Pharmaceuticals ↗

May 08, 2024

Via Benzinga

APLS Stock Earnings: Apellis Pharmaceuticals Misses EPS, Beats Revenue for Q1 2024 ↗

May 07, 2024

APLS stock results show that Apellis Pharmaceuticals missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024.

Via InvestorPlace

Expert Ratings For Apellis Pharmaceuticals ↗

April 15, 2024

Via Benzinga

If You Invested $1000 In This Stock 5 Years Ago, You Would Have $3,000 Today ↗

April 10, 2024

Via Benzinga

$1000 Invested In This Stock 5 Years Ago Would Be Worth $3,000 Today ↗

March 29, 2024

Via Benzinga

Decoding 15 Analyst Evaluations For Apellis Pharmaceuticals ↗

March 27, 2024

Via Benzinga

Peering Into Apellis Pharmaceuticals's Recent Short Interest ↗

March 15, 2024

Via Benzinga

Deep Dive Into Apellis Pharmaceuticals Stock: Analyst Perspectives (18 Ratings) ↗

February 28, 2024

Via Benzinga

ICU Medical To Rally Around 28%? Here Are 10 Top Analyst Forecasts For Wednesday ↗

February 28, 2024

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Via Benzinga

Earnings Scheduled For February 27, 2024 ↗

February 27, 2024

Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is expected to report quarterly loss at $0.07 per share on revenue of $100.49 million.

Via Benzinga

Here's How Much You Would Have Made Owning Apellis Pharmaceuticals Stock In The Last 5 Years ↗

February 22, 2024

Via Benzinga

$1000 Invested In Apellis Pharmaceuticals 5 Years Ago Would Be Worth This Much Today ↗

February 05, 2024

Via Benzinga

Critical Insights From Apellis Pharmaceuticals Analyst Ratings: What You Need To Know ↗

January 30, 2024

Via Benzinga

Apellis Pharmaceuticals Stock: A Deep Dive Into Analyst Perspectives (12 Ratings) ↗

January 09, 2024

Via Benzinga

Pinterest To Rally Over 20%? Here Are 10 Top Analyst Forecasts For Monday ↗

February 05, 2024

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Via Benzinga

Netflix To Rally Around 18%? Here Are 10 Top Analyst Forecasts For Wednesday ↗

January 24, 2024

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Via Benzinga

Netflix To Rally Over 13%? Here Are 10 Top Analyst Forecasts For Wednesday ↗

January 17, 2024

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Via Benzinga

10 Health Care Stocks With Whale Alerts In Today's Session ↗

January 15, 2024

Via Benzinga

10 Health Care Stocks With Whale Alerts In Today's Session ↗

December 25, 2023

Via Benzinga

Karuna Therapeutics Jumps Following Takeover By Bristol Myers, Joins Rocket Lab USA, Altair Engineering And Other Big Stocks Moving Higher On Friday ↗

December 22, 2023

U.S. stocks traded higher, with the Dow Jones index gaining around 50 points on Friday. Shares of Karuna Therapeutics, Inc. (NASDAQ: KRTX) rose sharply during Friday’s session following acquisition...

Via Benzinga

Topics Stocks

Why Is Complement-Mediated Focused Annexon Stock Trading Higher Today? ↗

December 21, 2023

On Wednesday, Annexon Inc (NASDAQ: ANNX) reported results from the Phase 1 single ascending dose (SAD) and multiple ascending dose (MAD) healthy volunteer study of ANX1502 that targets the active form...

Via Benzinga

Micron Technology To Rally Over 15%? Here Are 10 Top Analyst Forecasts For Friday ↗

December 15, 2023

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Via Benzinga

US Stocks Eye 7-Day Winning Streak As Mortgage Rates Fall Below 7%, Yields Tumble: What's Driving Markets Thursday? ↗

December 14, 2023

It’s shaping up to be a positive Thursday on Wall Street, with risk sentiment remaining robust after the Federal Reserve effectively opened the door to rate cuts in 2024.

Via Benzinga

Topics Economy

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

December 14, 2023

Via Benzinga

Why Is Apellis Pharmaceuticals Stock Trading Lower Today? ↗

December 14, 2023

Apellis Pharmaceuticals Inc (NASDAQ: APLS) announced an update on the ongoing review of its marketing application for intravitreal pegcetacoplan for geographic atrophy (GA) secondary to age-related...

Via Benzinga

Why Amtech Systems Shares Are Trading Higher By Over 30%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

December 14, 2023

Shares of Amtech Systems, Inc. (NASDAQ: ASYS) shares fell sharply during Thursday’s session after the company reported worse-than-expected fourth-quarter sales results and issued first-quarter sales...

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9

...

12 13 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Sections

Home
News
Entertainment
Local Events
Sports
Business
Obituaries
Photo Galleries
Videos
Online Features

Services

Subscription Services
Submission Forms
Classifieds
Place an Ad
Promote Your Event
Search
Weather

guymondailyherald.com
301 N. E. 4th Street
Guymon, OK 73942
Phone: 580-338-3355
Email: reporter@guymondailyherald.com

Facebook
Twitter
Instagram

Browser Compatibility

Your browser is out of date and potentially vulnerable to security risks.
We recommend switching to one of the following browsers:

Microsoft Edge Google Chrome Firefox

Guymon, OK (73942)

Today

Tonight

Apellis Pharmaceuticals, Inc. - Common Stock (NQ:APLS)

Headline News about Apellis Pharmaceuticals, Inc. - Common Stock

Sections

Services

Follow Us